Time point | Group C(n = 30) | Group D1(n = 30) | Group D2(n = 30) | P values(Pc and D1, Pc and D2, PD1 and D2) | |
---|---|---|---|---|---|
Concentration of sufentanil, μg/ml | 0.77 ± 0.11 | 0.76 ± 0.06 | 0.72 ± 0.06 | 0.163(0.552/ 0.063/ 0.200) | |
Dosage of sufentanil, ml | 1 h | 2.28 ± 0.41 | 2.00 ± 0.00 | 2.05 ± 0.15 | 0.003(0.001**/0.007**/0.531) |
2 h | 4.27 ± 0.41 | 4.05 ± 0.15 | 4.12 ± 0.29 | 0.013(0.011*/0.011*/1.000) | |
4 h | 8.40 ± 0.50 | 8.10 ± 0.30 | 8.13 ± 0.22 | 0.020(0.012*/0.020*/0.829) | |
8 h | 16.48 ± 0.57 | 16.16 ± 0.46 | 16.17 ± 0.34 | 0.058(0.032*/0.047*/0.866) | |
24 h | 48.55 ± 0.69 | 48.25 ± 0.77 | 48.17 ± 0.34 | 0.143(0.135/ 0.063/ 0.706) | |
48 h | 96.55 ± 0.69 | 96.30 ± 0.92 | 96.17 ± 0.35 | 0.227(0.258/ 0.092/ 0.570) | |
Needed additional self- administered sufentanil, n(%) | 48 h | 20(66.67%) | 10(33.33%) | 11(36.67%) | 0.051(0.030*/0.039*/0.930) |
Needed rescue analgesia, n(%) | 48 h | 0 (0%) | 0 (0%) | 0 (0%) | 1.000 |